14 Results for "

schizonts

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "schizonts" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-12784A
CAS No.: 152-53-4
Purity:  99.93%
Synonyms: Chlorguanide triazine hydrochloride
Research Areas:  

Infection Cancer

Cycloguanil (Chlorguanide triazine) hydrochloride is a dihydrofolate reductase (DHFR) inhibitor with an IC50 of 10.8 μM against human DHFR. Cycloguanil hydrochloride blocks the folate metabolic pathway, thereby affecting nucleotide synthesis and interfering with DNA replication. Cycloguanil inhibits DHFR in Plasmodium and is thus used in malaria research. Cycloguanil hydrochloride also potently inhibits DHFR in human cancer cells and blocks the transcriptional activity of STAT3, thereby exhibiting anticancer activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-156685
CAS No.: 2767264-57-1
Purity:  99.86%
Target:  

PI4K Parasite

Research Areas:  

Infection Metabolic Disease Cancer

EDI048 is an orally active, gut-restricted parasiticidal agent. EDI048 specifically binds to the ATP-binding site of Cryptosporidium phosphatidylinositol 4-kinase (CpPI (4) K), blocks parasite membrane biogenesis, arrests the pathogen at the schizont stage, and thus irreversibly clears the infection. EDI048 is rapidly converted to an inactive carboxylic acid metabolite via hepatic first-pass metabolism, with extremely low systemic exposure, good safety profile, and no cardiotoxicity, genotoxicity or off-target effects. EDI048 is used in studies of intestinal cryptosporidiosis in children .
loading...
    loading...
Cat. No.: HY-12912
CAS No.: 1513879-19-0
Purity:  99.42%
Target:  

PI4K Parasite

Research Areas:  

Infection

KDU691, an imidazopyrazine with potent anti-parasitic activity against blood stage schizonts, gametocytes and liver stages, is a Plasmodium PI4K inhibitor. KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites .
loading...
    loading...
Cat. No.: HY-B1036
CAS No.: 18507-89-6
Target:  

Parasite

Research Areas:  

Infection

Decoquinate is an orally active, selective inhibitor of the mitochondrial bc1 complex, targeting Eimeria spp. sporozoites and first generation schizonts, and Plasmodium spp. Decoquinate inhibits electron transfer by competitively binding to the mitochondrial cytochrome b system, blocking the parasite's energy metabolism, thereby inhibiting its development and reproduction. Decoquinate has significant anticoccidial activity, preventing intestinal damage and improving host growth performance, and also has inhibitory effects on the liver and blood stages of Plasmodium. Decoquinate is mainly used in veterinary research to prevent and treat coccidiosis in ruminants and poultry .
loading...
    loading...
Cat. No.: HY-126323
CAS No.: 2413716-15-9
Purity:  99.90%
Target:  

Parasite

Research Areas:  

Infection

TCMDC-135051 is a highly selective and potent protein kinase PfCLK3 inhibitor with low off-target toxicity. TCMDC-135051 prevents trophozoite-to-schizont transition, disrupts transcription and reduces transmission to the mosquito vector. TCMDC-135051 has antiparasiticidal activity (EC50=320 nM) .
loading...
    loading...
Cat. No.: HY-117015
CAS No.: 1038620-68-6
Purity:  99.44%
Target:  

Parasite

Research Areas:  

Infection

Purfalcamine is an orally active, selective Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) inhibitor with an IC50 of 17 nM and an EC50 of 230 nM. Purfalcamine has antimalarial activity and causes malaria parasites developmental arrest at the schizont stage .
loading...
    loading...
Cat. No.: HY-126323B
CAS No.: 2705545-47-5
Purity:  98.30%
Target:  

Parasite

Research Areas:  

Infection

TCMDC-135051 hydrochloride is a highly selective and potent protein kinase PfCLK3 inhibitor with low off-target toxicity. TCMDC-135051 hydrochloride prevents trophozoite-to-schizont transition, disrupts transcription and reduces transmission to the mosquito vector. TCMDC-135051 hydrochloride has antiparasiticidal activity (EC50=320 nM) .
loading...
    loading...
Cat. No.: HY-17036
CAS No.: 173531-58-3
Target:  

Parasite

Research Areas:  

Infection

Naphthoquine phosphate is a potent and orally active antimalarial agent. Naphthoquine phosphate has thorough killing function for various schizonts of plasmodia, including resistance of P. falciparum to Chloroquine .
loading...
    loading...
Cat. No.: HY-12784
CAS No.: 516-21-2
Synonyms: Chlorguanide triazine
Research Areas:  

Infection Cancer

Cycloguanil (Chlorguanide triazine) is a dihydrofolate reductase (DHFR) inhibitor with an IC50 of 10.8 μM against human DHFR. Cycloguanil blocks the folate metabolic pathway, thereby affecting nucleotide synthesis and interfering with DNA replication. Cycloguanil inhibits DHFR in Plasmodium and is thus used in malaria research. Cycloguanil also potently inhibits DHFR in human cancer cells and blocks the transcriptional activity of STAT3, thereby exhibiting anticancer activity .
loading...
    loading...
Cat. No.: HY-126323A
CAS No.: 2571578-55-5
Target:  

Parasite

Research Areas:  

Infection

TCMDC-135051 TFA is a highly selective and potent protein kinase PfCLK3 inhibitor with low off-target toxicity. TCMDC-135051 TFA prevents trophozoite-to-schizont transition, disrupts transcription and reduces transmission to the mosquito vector. TCMDC-135051 TFA has antiparasiticidal activity (EC50=320 nM) .
loading...
    loading...
Cat. No.: HY-W856920
CAS No.: 4042-30-2
Target:  

Parasite

Research Areas:  

Infection

Parvaquone is an antiparasite agent with an in vitro ED50 of 0.006 mg/L. Parvaquone reduces the proportion of Theileria parva schizont-infected cells. Parvaquone can be used for the research of east coast fever (Theileria parva infection) .
loading...
    loading...
Cat. No.: HY-18746
CAS No.: 1513879-18-9
Target:  

Parasite PI4K

Research Areas:  

Infection

KAI-407 is an orally active inhibitor of Plasmodium PI4K kinase, which can broadly inhibit multiple stages of the parasite lifecycle. KAI-407 exhibits EC50s of for the blood stage of malignant Plasmodium of 81 nM; for the liver schizonts of P. yoelii of 88 nM; and IC50s for the liver schizonts and dormant bodies of P. cynomolgi of 0.64 μM and 0.69 μM respectively. KAI-407 can prevent Plasmodium berghei infection 100%. KAI-407 can be used for the study of vivax malaria .
loading...
    loading...
Cat. No.: HY-184395
Target:  

Parasite

Research Areas:  

Infection

HLQ-102 is an orally active parasite cytochrome bc1 complex Qi site binder. HLQ-102 inhibits the growth of Plasmodium. HLQ-102 exhibits antimalarial activity against Plasmodium in mice. HLQ-102 can be used in malaria-related research .
loading...
    loading...
Cat. No.: HY-184661
CAS No.: 2581277-82-7
Target:  

Parasite

Research Areas:  

Infection

MMV022224 is an antimalarial agent that acts by selectively binding to and inhibiting the enzymatic activity of PfPK6. MMV022224 disrupts hemoglobin catabolism, induces peptide accumulation, and targets the ring and trophozoite stages of Plasmodium falciparum. MMV022224 can be used in malaria-related research .
loading...
    loading...
  • 1